Castle Private Equity AG (XSWX:CPEN) Research & Development: CHF0.00 Mil (TTM As of Dec. 2025)


XSWX:CPEN Castle Private Equity AG XSWX:CPEN
32 GF Score
Price CHF3.00
! 2 Warning Signs
View Full Analysis

What is Castle Private Equity AG Research & Development?

Castle Private Equity AG XSWX:CPEN +4.90% 32 Research & Development is CHF0.00 Mil as of Dec. 2025. GuruFocus rates XSWX:CPEN with a GF Score™ of 32/100. The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Castle Private Equity AG's Research & Development for the six months ended in Dec. 2025 was CHF0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was CHF0.00 Mil.

Castle Private Equity AG  (XSWX:CPEN) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Castle Private Equity AG Research & Development Related Terms

Castle Private Equity AG Research & Development Historical Data

* Premium members only.

The historical data trend for Castle Private Equity AG's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Castle Private Equity AG Research & Development Chart

Castle Private Equity AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Castle Private Equity AG Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XSWX:CPEN
32GF Score
Castle Private Equity AG XSWX:CPEN
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Castle Private Equity AG Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of CHF0.00 Mil mean?
Castle Private Equity AG (XSWX:CPEN) has a Research & Development of CHF0.00 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Castle Private Equity AG and its competitors.
Is Castle Private Equity AG's Research & Development too high?
Castle Private Equity AG's current Research & Development is CHF0.00 Mil. Overall, Castle Private Equity AG has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Castle Private Equity AG's Research & Development compare to BLK and BX?
Castle Private Equity AG's Research & Development of CHF0.00 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Asset Management company?
A good Research & Development depends on the Asset Management industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Castle Private Equity AG and its competitors. Castle Private Equity AG's current Research & Development is CHF0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Castle Private Equity AG stock overvalued right now?
Castle Private Equity AG (XSWX:CPEN) has a current Research & Development of CHF0.00 Mil. The current Research & Development is CHF0.00 Mil. Castle Private Equity AG's overall GF Score™ is 32/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Castle Private Equity AG (XSWX:CPEN), the current Research & Development is CHF0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Castle Private Equity AG Business Description

Other Exchanges 0QOO:UKCLQN:Germany
Address Schutzenstrasse 6, Pfaffikon, CHE, CH-8808
Castle Private Equity AG is engaged in private equity investments. Its investment policy aims at maximization of the long-term value advancement by way of realizing the Group's funds by harvesting the portfolio of private equity investments as their underlying assets are realized. The company has a geographic presence in Asia, Europe, North America, and Others.
32GF Score

Get the complete analysis for XSWX:CPEN

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF3.00
Price